# Rasio Therapeutics, Inc. — Form D

Rasio Therapeutics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-26. The offering totals $1.5M, of which $1.5M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2021-11-26
- Form: D
- Accession: 0001895690-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $1.5M
- Investors: 2
- Date of first sale: 2021-11-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-422550

## Issuer

- Name: Rasio Therapeutics, Inc.
- CIK: 0001895690
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 1100 WICOMICO STREET, BALTIMORE, MD, 21230
- Phone: 6018180612

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Sujuan Ba | Director | Bethesda, MA |
| Raju Kucherlapati | Director | Houston, TX |
| Ken Malone | Director | Baltimore, MD |
| Ken Malone | Executive Officer | Baltimore, MD |

## More

- [CIK 1895690 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1895690&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001895690-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.